221 related articles for article (PubMed ID: 38395987)
1. A pilot investigation of the association between HIV-1 Vpr amino acid sequence diversity and the tryptophan-kynurenine pathway as a potential mechanism for neurocognitive impairment.
Asia LK; Van Vuren EJ; Lindeque Z; Williams ME
Virol J; 2024 Feb; 21(1):47. PubMed ID: 38395987
[TBL] [Abstract][Full Text] [Related]
2. A Pilot Investigation of the Association Between Vpr Amino Acid Substitutions and Peripheral Immune Marker Levels in People With Human Immunodeficiency Virus: Implications for Neurocognitive Impairment.
Asia LK; Van Vuren EJ; Kruger IM; Williams ME
Open Forum Infect Dis; 2024 Mar; 11(3):ofae111. PubMed ID: 38524224
[TBL] [Abstract][Full Text] [Related]
3. Age-Associated Gut Dysbiosis, Marked by Loss of Butyrogenic Potential, Correlates With Altered Plasma Tryptophan Metabolites in Older People Living With HIV.
Ghare S; Singhal R; Bryant V; Gautam S; Tirumala CC; Srisailam PK; Reyes-Vega A; Ghooray D; McClain CJ; Hoffman K; Petrosino J; Bryant K; Govind V; Cohen R; Cook RL; Barve S
J Acquir Immune Defic Syndr; 2022 Feb; 89(Suppl 1):S56-S64. PubMed ID: 35015746
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous measurement of kynurenine metabolites and explorative metabolomics using liquid chromatography-mass spectrometry: A novel accurate method applied to serum and plasma samples from a large healthy cohort.
Eggertsen PP; Hansen J; Andersen ML; Nielsen JF; Olsen RKJ; Palmfeldt J
J Pharm Biomed Anal; 2023 Apr; 227():115304. PubMed ID: 36827735
[TBL] [Abstract][Full Text] [Related]
5. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
[TBL] [Abstract][Full Text] [Related]
6. [Quantitative analysis of tryptophan and its metabolites in urine by ultra performance liquid chromatography-tandem mass spectrometry].
Li H; Cui L; Zhang G; Zhang M; Jiao L; Wu W
Se Pu; 2021 May; 39(5):518-525. PubMed ID: 34227336
[TBL] [Abstract][Full Text] [Related]
7. Influence of periodontal inflammation on tryptophan-kynurenine metabolism: a cross-sectional study.
Kurgan Ş; Önder C; Balcı N; Akdoğan N; Altıngöz SM; Serdar MA; Günhan M
Clin Oral Investig; 2022 Sep; 26(9):5721-5732. PubMed ID: 35588020
[TBL] [Abstract][Full Text] [Related]
8. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans.
Yan EB; Frugier T; Lim CK; Heng B; Sundaram G; Tan M; Rosenfeld JV; Walker DW; Guillemin GJ; Morganti-Kossmann MC
J Neuroinflammation; 2015 May; 12():110. PubMed ID: 26025142
[TBL] [Abstract][Full Text] [Related]
9. Altered neopterin and IDO in kynurenine metabolism based on LC-MS/MS metabolomics study: Novel therapeutic checkpoints for type 2 diabetes mellitus.
Liu Z; Ma Z; Jin L; Nizhamuding X; Zeng J; Zhang T; Zhang J; Wang J; Zhao H; Zhou W; Zhang C
Clin Chim Acta; 2024 Apr; 557():117859. PubMed ID: 38518968
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms.
Aeinehband S; Brenner P; Ståhl S; Bhat M; Fidock MD; Khademi M; Olsson T; Engberg G; Jokinen J; Erhardt S; Piehl F
Brain Behav Immun; 2016 Jan; 51():47-55. PubMed ID: 26189678
[TBL] [Abstract][Full Text] [Related]
11. Dynamic changes in kynurenine pathway metabolites in multiple sclerosis: A systematic review.
Fathi M; Vakili K; Yaghoobpoor S; Tavasol A; Jazi K; Mohamadkhani A; Klegeris A; McElhinney A; Mafi Z; Hajiesmaeili M; Sayehmiri F
Front Immunol; 2022; 13():1013784. PubMed ID: 36426364
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of kynurenine pathway and potential dynamic changes of kynurenine in schizophrenia: A systematic review and meta-analysis.
Cao B; Chen Y; Ren Z; Pan Z; McIntyre RS; Wang D
Neurosci Biobehav Rev; 2021 Apr; 123():203-214. PubMed ID: 33513412
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum levels of kynurenine pathway metabolites in patients with Behçet disease.
Eryavuz Onmaz D; Tezcan D; Abusoglu S; Sivrikaya A; Kuzu M; Yerlikaya FH; Yilmaz S; Unlu A
Amino Acids; 2022 Jun; 54(6):877-887. PubMed ID: 35604497
[TBL] [Abstract][Full Text] [Related]
14. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression.
Raison CL; Dantzer R; Kelley KW; Lawson MA; Woolwine BJ; Vogt G; Spivey JR; Saito K; Miller AH
Mol Psychiatry; 2010 Apr; 15(4):393-403. PubMed ID: 19918244
[TBL] [Abstract][Full Text] [Related]
15. Impaired kynurenine metabolism in patients with primary Sjögren's syndrome.
Eryavuz Onmaz D; Tezcan D; Abusoglu S; Sak F; Humeyra Yerlikaya F; Yilmaz S; Abusoglu G; Kazim Korez M; Unlu A
Clin Biochem; 2023 Apr; 114():1-10. PubMed ID: 36681140
[TBL] [Abstract][Full Text] [Related]
16. Tryptophan-kynurenine metabolism during acute alcohol withdrawal in patients with alcohol use disorder: The role of immune activation.
Mechtcheriakov S; Gleissenthall GV; Geisler S; Arnhard K; Oberacher H; Schurr T; Kemmler G; Unterberger C; Fuchs D
Alcohol Clin Exp Res; 2022 Sep; 46(9):1648-1656. PubMed ID: 35938556
[TBL] [Abstract][Full Text] [Related]
17. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
[TBL] [Abstract][Full Text] [Related]
18. Associations between circulating interferon and kynurenine/tryptophan pathway metabolites: support for a novel potential mechanism for cognitive dysfunction in SLE.
Anderson EW; Jin Y; Shih A; Arazi A; Goodwin S; Roeser J; Furie RA; Aranow C; Volpe B; Diamond B; Mackay M
Lupus Sci Med; 2022 Nov; 9(1):. PubMed ID: 36384965
[TBL] [Abstract][Full Text] [Related]
19. Tryptophan, kynurenine pathway, and diabetic ketoacidosis in type 1 diabetes.
Hoffman WH; Whelan SA; Lee N
PLoS One; 2021; 16(7):e0254116. PubMed ID: 34280211
[TBL] [Abstract][Full Text] [Related]
20. Associations of Parameters of the Tryptophan-Kynurenine Pathway with Cardiovascular Risk Factors in Hypertensive Patients.
Theiler-Schwetz V; Trummer C; Grübler MR; Keppel MH; Zittermann A; Tomaschitz A; März W; Meinitzer A; Pilz S
Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
